Larvol Delta - Afmed-Announces-Positive-Results-Demonstrating-Safety-and-Efcacy-of-Acimtamig-and-AlloNK-Combination-in-RelapsedRefractory-Classical-Hodgkin-Lymphoma-RR-cHL-Patients

AlloNK (GCC4001) - GC Biopharma

acimtamig (AFM13) - Affimed

https://www.globenewswire.com/news-release/2024/12/08/2993398/0/en/Affimed-Announces-Positive-Results-Demonstrating-Safety-and-Efficacy-of-Acimtamig-and-AlloNK-Combination-in-Relapsed-Refractory-Classical-Hodgkin-Lymphoma-R-R-cHL-Patients.html

Dec 8, 2024

SHARE THIS

Print
Email
More sharing

Reddit

StumbleUpon

Delicious

Prev Next